Pregnanediols and Neonatal Hyperbilirubinemia
- 1 April 1966
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Pediatrics & Adolescent Medicine
- Vol. 111 (4) , 353-356
- https://doi.org/10.1001/archpedi.1966.02090070051003
Abstract
IT SEEMS well established that there is a relationship between breast feeding and neonatal hyperbilirubinemia.1-5 Transient unconjugated hyperbilirubinemia observed for several days in the neonatal period, and clinically referred to as physiologic jaundice, is believed to be the result of a maturational delay in the development of the hepatic enzymes associated with bilirubin conjugation in the liver.6-8 Both pregnane-3α, 20α- and pregnane-3α,20β-diol show in vitro inhibition of conjugation in a system using o-aminophenol and bilirubin as substrates with microsomal fractions prepared from rat and guinea pig liver.9-11 An in vitro inhibition is also demonstrable with breast milk of some nursing infants with so-called physiologic hyperbilirubinemia in the same system.12 Arias et al have reported the isolation of the 3α,20β isomer from breast milk.2 They have estimated that approximately 1 mg of the substance is excreted per day in the mother's milk. Two full-term infants orallyThis publication has 5 references indexed in Scilit:
- Breast-Milk JaundiceAmerican Journal of Diseases of Children, 1965
- Prolonged Neonatal Unconjugated Hyperbilirubinemia Associated with Breast Feeding and a Steroid, Pregnane-3 (Alpha), 20 (Beta)-Diol, in Maternal Milk That Inhibits Glucuronide Formation In Vitro*Journal of Clinical Investigation, 1964
- Developmental pattern of glucuronide formation in rat and guinea pig liverAmerican Journal of Physiology-Legacy Content, 1963
- INHIBITORS OF BILIRUBIN CONJUGATION IN NEW-BORN INFANT SERUM AND MALE URINE1963
- STUDIES ON THE NEONATAL DEVELOPMENT OF THE GLUCURONIDE CONJUGATING 12Journal of Clinical Investigation, 1958